A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2
| Autor: | Shaverdashvili, Khvaramze, Reyes, Vincent, Wang, Hong, Mehta, Dhaval, Marsh, Christopher, Waas, John K., VanderWeele, Robert A., Peracha, Sajid M., Liang, Hongmei, Socinski, Mark A., Gerber, David E., Dowell, Jonathan E., Villaruz, Liza C. |
|---|---|
| Zdroj: | In eClinicalMedicine December 2023 66 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|